We thought that people were bringing it upon themselves because they were eating too much and lazy, Hurtado Andrade said, but the reality is that we know that there is a direct genetic origin to developing obesity, so we must consider it like any other disease. In 2017, about 41.9% of Americans were diagnosed with obesity
Novo Nordisk's phase 3 data showed 22.1% weight loss, positioning it between semaglutide and retatrutide
Most people find it okay, with only a few minor issues
Compounded versions use the same active ingredient as the brand-name drug, but they are not FDA-approved as finished products the way Ozempic, Wegovy, and Zepbound are
The FDA-approved dose of tesamorelin (Egrifta) is 2 mg subcutaneously once daily for HIV-associated lipodystrophy
I wish , but sadly, no effect of dark chocolate on GLP-1 either